Section 6 of 6
References
199 sources
- Abbott et al. (2024) (opens in a new tab)
- Acadia DAYBUE prescribing information (2026) (opens in a new tab)
- Acadia Pharmaceuticals Form 10-K (2026) (opens in a new tab)
- Amir et al. (1999) (opens in a new tab)
- Anderson et al. (2014) (opens in a new tab)
- Ben-Zeev et al. (2026) (opens in a new tab)
- Berry-Kravis et al. (2026a) (opens in a new tab)
- Berry-Kravis et al. (2026b) (opens in a new tab)
- Bienvenu et al. (2006) (opens in a new tab)
- Bisgaard et al. (2021) (opens in a new tab)
- Blue Shield of California (2023) (opens in a new tab)
- Boban et al. (2018) (opens in a new tab)
- Bond et al. (2025) (opens in a new tab)
- Buchanan et al. (2022) (opens in a new tab)
- Byiers et al. (2014) (opens in a new tab)
- CDA-AMC trofinetide reimbursement recommendation (2025) (opens in a new tab)
- CDA-AMC trofinetide reimbursement review (2025) (opens in a new tab)
- Cherchi et al. (2023) (opens in a new tab)
- Cherchi et al. (2024) (opens in a new tab)
- Choi et al. (2025) (opens in a new tab)
- ClinicalTrials.gov NCT00299312 (opens in a new tab)
- ClinicalTrials.gov NCT02738281 (opens in a new tab)
- ClinicalTrials.gov NCT04181723 (opens in a new tab)
- ClinicalTrials.gov NCT04279314 (opens in a new tab)
- ClinicalTrials.gov NCT04776746 (opens in a new tab)
- ClinicalTrials.gov NCT04988867 (opens in a new tab)
- ClinicalTrials.gov NCT05606614 (opens in a new tab)
- ClinicalTrials.gov NCT05898620 (opens in a new tab)
- ClinicalTrials.gov NCT06152237 (opens in a new tab)
- ClinicalTrials.gov NCT07480564 (opens in a new tab)
- Corchón et al. (2018) (opens in a new tab)
- Cosand et al. (2026) (opens in a new tab)
- Crosson et al. (2017) (opens in a new tab)
- Cuddapah et al. (2014) (opens in a new tab)
- Cutri-French et al. (2020) (opens in a new tab)
- Desnous et al. (2024) (opens in a new tab)
- Devidze et al. (2023) (opens in a new tab)
- Downs et al. (2009) (opens in a new tab)
- Downs et al. (2014) (opens in a new tab)
- Downs et al. (2016) (opens in a new tab)
- Downs et al. (2018) (opens in a new tab)
- Downs et al. (2019) (opens in a new tab)
- Downs et al. (2024) (opens in a new tab)
- EMA Daybu EPAR (2026) (opens in a new tab)
- EMA paediatric investigation plan decision (2025) (opens in a new tab)
- Epstein et al. (2016) (opens in a new tab)
- Fang et al. (2022) (opens in a new tab)
- FDA Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations draft guidance (2025) (opens in a new tab)
- FDA Orphan Drug Designations and Approvals (2020) (opens in a new tab)
- FDA UNII NVK87P6NXW (opens in a new tab)
- Fehr et al. (2010) (opens in a new tab)
- Fehr et al. (2011) (opens in a new tab)
- Fonzo et al. (2020) (opens in a new tab)
- Freilinger et al. (2010) (opens in a new tab)
- Fu et al. (2020a) (opens in a new tab)
- Fu et al. (2020b) (opens in a new tab)
- Galán-Olleros et al. (2024) (opens in a new tab)
- Glaze et al. (2010) (opens in a new tab)
- Gold et al. (2024) (opens in a new tab)
- Greenwood Genetic Center (opens in a new tab)
- Guy et al. (2007) (opens in a new tab)
- Hagberg et al. (1983) (opens in a new tab)
- Haque et al. (2023) (opens in a new tab)
- Haque et al. (2024) (opens in a new tab)
- Haque et al. (2025) (opens in a new tab)
- Haque et al. (2026a) (opens in a new tab)
- Haque et al. (2026b) (opens in a new tab)
- Hendrie et al. (2011) (opens in a new tab)
- Hryniewiecka-Jaworska et al. (2025) (opens in a new tab)
- ICH E11A guideline (2024) (opens in a new tab)
- Jefferson et al. (2016) (opens in a new tab)
- Kaufmann et al. (2024) (opens in a new tab)
- Kaur and Christodoulou (2025) (opens in a new tab)
- Keeley et al. (2025) (opens in a new tab)
- Killian et al. (2016) (opens in a new tab)
- Killian et al. (2017) (opens in a new tab)
- Kim et al. (2024) (opens in a new tab)
- Kirby et al. (2010) (opens in a new tab)
- Krajnc (2015) (opens in a new tab)
- Kyle et al. (2018) (opens in a new tab)
- Lane et al. (2011) (opens in a new tab)
- Laurvick et al. (2006) (opens in a new tab)
- Levy-Shraga et al. (2025) (opens in a new tab)
- Lotan (2019) (opens in a new tab)
- MacKay et al. (2018) (opens in a new tab)
- Maheshwari (2018) (opens in a new tab)
- Managed Healthcare Executive (2023) (opens in a new tab)
- May et al. (2023) (opens in a new tab)
- May et al. (2024a) (opens in a new tab)
- May et al. (2024b) (opens in a new tab)
- May et al. (2024c) (opens in a new tab)
- McArthur and Budden (1998) (opens in a new tab)
- McGraw et al. (2023) (opens in a new tab)
- McKnight et al. (2022) (opens in a new tab)
- Montgomery et al. (2026) (opens in a new tab)
- Moore et al. (2024) (opens in a new tab)
- Motil et al. (2024) (opens in a new tab)
- Nemours (2026) (opens in a new tab)
- Neul et al. (2008) (opens in a new tab)
- Neul et al. (2010) (opens in a new tab)
- Neul et al. (2014) (opens in a new tab)
- Neul et al. (2015) (opens in a new tab)
- Neul et al. (2019) (opens in a new tab)
- Neul et al. (2022) (opens in a new tab)
- Neul et al. (2023a) (opens in a new tab)
- Neul et al. (2023b) (opens in a new tab)
- Neul et al. (2023c) (opens in a new tab)
- Neul et al. (2026) (opens in a new tab)
- Neurogene third quarter 2026 results announcement (2026) (opens in a new tab)
- NINDS (opens in a new tab)
- Okposo et al. (2023) (opens in a new tab)
- Patel et al. (2026) (opens in a new tab)
- Percy et al. (2010) (opens in a new tab)
- Percy et al. (2024a) (opens in a new tab)
- Percy et al. (2024b) (opens in a new tab)
- Percy et al. (2025a) (opens in a new tab)
- Percy et al. (2025b) (opens in a new tab)
- Peron et al. (2022) (opens in a new tab)
- Peters et al. (2026) (opens in a new tab)
- Petriti et al. (2023) (opens in a new tab)
- Pimprikar et al. (2026) (opens in a new tab)
- Prange et al. (2026) (opens in a new tab)
- Prasad et al. (2022a) (opens in a new tab)
- Prasad et al. (2022b) (opens in a new tab)
- Pulles et al. (2026) (opens in a new tab)
- Quarmley et al. (2026) (opens in a new tab)
- Rajagopalan et al. (2025) (opens in a new tab)
- Rashid et al. (2025a) (opens in a new tab)
- Rashid et al. (2025b) (opens in a new tab)
- Rashid et al. (2026a) (opens in a new tab)
- Rashid et al. (2026b) (opens in a new tab)
- Rashid et al. (2026c) (opens in a new tab)
- Raspa et al. (2020) (opens in a new tab)
- Rossignol et al. (2023) (opens in a new tab)
- Rossignol et al. (2024a) (opens in a new tab)
- Rossignol et al. (2024b) (opens in a new tab)
- Rossignol et al. (2025a) (opens in a new tab)
- Rossignol et al. (2025b) (opens in a new tab)
- Rozensztrauch et al. (2021) (opens in a new tab)
- Sadhu et al. (2024) (opens in a new tab)
- Samanta (2026) (opens in a new tab)
- Sarajlija et al. (2015) (opens in a new tab)
- Sigafoos et al. (2023) (opens in a new tab)
- Singh et al. (2020) (opens in a new tab)
- Sinnett et al. (2021) (opens in a new tab)
- Skrobanski et al. (2025) (opens in a new tab)
- Stallworth et al. (2019) (opens in a new tab)
- Stone et al. (2023) (opens in a new tab)
- Strugnell et al. (2020) (opens in a new tab)
- Symons et al. (2013) (opens in a new tab)
- Ta et al. (2022) (opens in a new tab)
- Tarquinio et al. (2012) (opens in a new tab)
- Tarquinio et al. (2015a) (opens in a new tab)
- Tarquinio et al. (2015b) (opens in a new tab)
- Tarquinio et al. (2017) (opens in a new tab)
- Tarquinio et al. (2018) (opens in a new tab)
- Tarquinio et al. (2026) (opens in a new tab)
- Tascini et al. (2022) (opens in a new tab)
- Taylor et al. (2023) (opens in a new tab)
- Taysha Gene Therapies 54th CNS Annual Meeting supplemental analysis announcement (2025) (opens in a new tab)
- Taysha Gene Therapies adolescent eligibility announcement (2023) (opens in a new tab)
- Taysha Gene Therapies August 2026 corporate presentation (2026) (opens in a new tab)
- Taysha Gene Therapies Breakthrough Therapy designation announcement (2025) (opens in a new tab)
- Taysha Gene Therapies Catalent commercial manufacturing announcement (2026) (opens in a new tab)
- Taysha Gene Therapies clinical program update announcement (2024) (opens in a new tab)
- Taysha Gene Therapies European orphan designation announcement (2021) (opens in a new tab)
- Taysha Gene Therapies Fast Track designation announcement (2023) (opens in a new tab)
- Taysha Gene Therapies first participant dosed announcement (2023) (opens in a new tab)
- Taysha Gene Therapies first pediatric participant dosed announcement (2024) (opens in a new tab)
- Taysha Gene Therapies first quarter 2026 results announcement (2026) (opens in a new tab)
- Taysha Gene Therapies first-cohort data HCP presentation (2024) (opens in a new tab)
- Taysha Gene Therapies Form 10-K (2026) (opens in a new tab)
- Taysha Gene Therapies full rights announcement (2025) (opens in a new tab)
- Taysha Gene Therapies full-year 2024 results announcement (2025) (opens in a new tab)
- Taysha Gene Therapies full-year 2025 results announcement (2026) (opens in a new tab)
- Taysha Gene Therapies healthcare professionals page (opens in a new tab)
- Taysha Gene Therapies June 2026 program update presentation (2026) (opens in a new tab)
- Taysha Gene Therapies low dose cohort data announcement (2024) (opens in a new tab)
- Taysha Gene Therapies orphan drug and rare pediatric disease designation announcement (2020) (opens in a new tab)
- Taysha Gene Therapies our science page (opens in a new tab)
- Taysha Gene Therapies pivotal program progress announcement (2026) (opens in a new tab)
- Taysha Gene Therapies pivotal trial design announcement (2025) (opens in a new tab)
- Taysha Gene Therapies REVEAL pivotal dosing completion announcement (2026) (opens in a new tab)
- Taysha Gene Therapies RMAT designation announcement (2024) (opens in a new tab)
- Taysha Gene Therapies second quarter 2025 results announcement (2025) (opens in a new tab)
- Taysha Gene Therapies second quarter 2026 results announcement (2026) (opens in a new tab)
- Taysha Gene Therapies third quarter 2024 results announcement (2024) (opens in a new tab)
- Taysha Gene Therapies third quarter 2026 Form 10-Q (2026) (opens in a new tab)
- Taysha Gene Therapies third quarter 2026 results announcement (2026) (opens in a new tab)
- Townend et al. (2016) (opens in a new tab)
- Townend et al. (2020) (opens in a new tab)
- Trappe et al. (2001) (opens in a new tab)
- Vidal et al. (2017) (opens in a new tab)
- Vignoli et al. (2025) (opens in a new tab)
- Vilvarajan et al. (2023) (opens in a new tab)
- WHO Proposed INN List 130 (2023) (opens in a new tab)
- Wiedemann et al. (2019) (opens in a new tab)
- Wong et al. (2018) (opens in a new tab)
- Young et al. (2007) (opens in a new tab)